JPWO2023120551A5 - - Google Patents
Info
- Publication number
- JPWO2023120551A5 JPWO2023120551A5 JP2023569475A JP2023569475A JPWO2023120551A5 JP WO2023120551 A5 JPWO2023120551 A5 JP WO2023120551A5 JP 2023569475 A JP2023569475 A JP 2023569475A JP 2023569475 A JP2023569475 A JP 2023569475A JP WO2023120551 A5 JPWO2023120551 A5 JP WO2023120551A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- buprenorphine
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021206572 | 2021-12-21 | ||
| PCT/JP2022/047004 WO2023120551A1 (ja) | 2021-12-21 | 2022-12-21 | 自閉スペクトラム症治療のためのオピオイドの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023120551A1 JPWO2023120551A1 (https=) | 2023-06-29 |
| JPWO2023120551A5 true JPWO2023120551A5 (https=) | 2025-12-16 |
Family
ID=86902678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023569475A Pending JPWO2023120551A1 (https=) | 2021-12-21 | 2022-12-21 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250073226A1 (https=) |
| EP (1) | EP4454649A4 (https=) |
| JP (1) | JPWO2023120551A1 (https=) |
| CN (1) | CN118434419A (https=) |
| TW (1) | TW202329963A (https=) |
| WO (1) | WO2023120551A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5931884B2 (ja) * | 2010-10-07 | 2016-06-08 | カリフォルニア インスティチュート オブ テクノロジー | 自閉症の生菌療法 |
| WO2013042054A1 (en) | 2011-09-19 | 2013-03-28 | Carmel - Haifa University Economic Corporation Ltd. | Buprenorphine for the treatment of acute suicidality |
| EP2859890A3 (en) * | 2011-10-31 | 2015-08-05 | The Johns Hopkins University | Methods and compositions for treatment of autism |
| CA3023014C (en) * | 2017-11-06 | 2023-09-26 | Stalicla Sa | Pharmaceutical composition for treatment of autism |
| US11491144B2 (en) * | 2018-03-30 | 2022-11-08 | The Florida State University Research Foundation, Incorporated | Methods of treating fragile X mental retardation syndrome |
| US11160843B2 (en) | 2018-04-30 | 2021-11-02 | Yale University | Oxytocin and opioid antagonists for treatment of social dysfunction disorder |
-
2022
- 2022-12-21 JP JP2023569475A patent/JPWO2023120551A1/ja active Pending
- 2022-12-21 US US18/722,305 patent/US20250073226A1/en active Pending
- 2022-12-21 TW TW111149205A patent/TW202329963A/zh unknown
- 2022-12-21 EP EP22911253.7A patent/EP4454649A4/en active Pending
- 2022-12-21 CN CN202280084611.1A patent/CN118434419A/zh active Pending
- 2022-12-21 WO PCT/JP2022/047004 patent/WO2023120551A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2572768B2 (ja) | レボドパメチルエステルを有効成分とするパ−キンソン病治療剤 | |
| JP2023041862A5 (https=) | ||
| JP2002539245A5 (https=) | ||
| CA2393437A1 (en) | Exo-s-mecamylamine formulation and use in treatment | |
| JPH06102622B2 (ja) | 肥満の治療 | |
| JP2010523587A5 (https=) | ||
| IL300151A (en) | Combinations for cancer treatment | |
| JP2018507243A5 (https=) | ||
| CN1856339A (zh) | 肺动脉高血压症治疗的伊洛前列素联合疗法 | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2022502498A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| BG60400B2 (bg) | Синергитични фармацевтични препарати, тяхното получаване и употребата им | |
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| RU99119233A (ru) | Фармацевтические композиции, содержащие ибупрофен и домперидон для лечения мигрени | |
| RO117147B1 (ro) | Compozitie contra tusei | |
| JP2872809B2 (ja) | モノシアロガングリオシドｇｍ▲下１▼またはその誘導体を含有する，パーキンソン病の治療に適する医薬組成物 | |
| KR20240069750A (ko) | 신경 장애의 치료 | |
| JPWO2023120551A5 (https=) | ||
| KR101267771B1 (ko) | 약제 조합을 이용한 치료 방법 및 이에 적합한 약제 조합 | |
| JP2021521103A5 (https=) | ||
| JP2021530568A5 (https=) | ||
| IL320111A (en) | Cnp compounds | |
| Klinke et al. | A randomized double-blind comparison of diltiazem and nifedipine in stable angina | |
| JPWO2021050203A5 (https=) |